SingulOmics Corporation was established in 2016 in New York as a genomic research and service company specializing in the emerging field of single-cell omics. Building on the unmatched expertise in single-cell genomics, transcriptomics, and epigenomics developed since the mid-2000s at Albert Einstein College of Medicine, our mission is to develop and provide high-quality, innovative single-cell services to research communities around the world. In addition, our end-to-end single-cell sequencing and analysis solutions enable global biopharmaceutical and diagnostic companies to accelerate target discovery and biomarker development.
We are proud to offer:
- Single Cell Genomics
- Single Cell Transcriptomics
- Single Cell Epigenomics
- Bulk RNA-Seq Service
Check out SingulOmics in the News:
- The Singles Seen: Sequencing Gets Specific - Science, November 2, 2017
- Data Published in Nature Methods Demonstrate Breakthrough Ability to Accurately Detect Somatic Single Nucleotide Variations in Single Cells - Singulomics Press Release, March 20, 2017
- Einstein Researchers Publish Single-Cell Sequencing Prep Method, Launch Firm to Provide Service - Genomeweb, April 21, 2017
- Tool Can Accurately Detect Single Nucleotide Variations in Individual Cells - Labroots, March 20, 2017
- Single Cell Genomics Markets, 2024 - Research and Markets, June 12, 2019